Efficacy and Safety of Intravitreal Aflibercept Treat-And-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR
Version 3 2020-11-05, 11:50
Version 2 2020-11-04, 13:55
Version 1 2020-01-28, 09:07
figure
posted on 2020-11-05, 11:50 authored by Masahito Ohji, Kanji Takahashi, Annabelle A. Okada, Masato Kobayashi, Yoshimi Matsuda, Yasuhiro Terano, ALTAIR Investigators<p></p><p><strong>Article full
text</strong></p>
<p><br>
The above summary slide, video abstract, script and storyboard represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2020. </p><br><p></p>
